| 1 | secondary | 31,196 |
| 2 | co-primary | 281 |
| 3 | coprimary | 226 |
| 4 | harmonizing | 76 |
| 5 | exposure/response | 10 |
| 6 | hiv/sti/pregnancy | 4 |
| 7 | late-appearing | 4 |
| 8 | non-vocational | 4 |
| 9 | reperfusion-related | 4 |
| 10 | stimulant-use | 4 |
| 11 | time/cost | 4 |
| 12 | ttt/ttt | 4 |
| 13 | 'rapidly | 3 |
| 14 | carer-related | 3 |
| 15 | harms/harm-related | 3 |
| 16 | co-secondary | 2 |
| 17 | developmental/cognitive | 2 |
| 18 | fetal/neonatal/infant | 2 |
| 19 | icu-related | 2 |
| 20 | interventionsprimary | 2 |
| 21 | multiple-approach | 2 |
| 22 | non-substantive | 2 |
| 23 | poor/death | 2 |
| 24 | prolapse-specific | 2 |
| 25 | secondary/exploratory | 2 |
| 26 | secundary | 2 |
| 27 | smoker-level | 2 |
| 28 | surgeon-administered | 2 |
| 29 | treatment.secondary | 2 |
| 30 | within-drug | 2 |
| 31 | xylazine-induced | 2 |
| 32 | 'eczema | 1 |
| 33 | .feasibility | 1 |
| 34 | /secondary | 1 |
| 35 | 23-step | 1 |
| 36 | 6-7-year | 1 |
| 37 | adult-provided | 1 |
| 38 | after-baseline | 1 |
| 39 | agency-level | 1 |
| 40 | b-efficacy | 1 |
| 41 | background/ | 1 |
| 42 | behavioral/physiological | 1 |
| 43 | binary/dichotomous | 1 |
| 44 | c-radiographic | 1 |
| 45 | careconnections | 1 |
| 46 | caseworker-level | 1 |
| 47 | cognitive/psychosocial | 1 |
| 48 | composite-outcomes | 1 |
| 49 | consultations.commonly-occurring | 1 |
| 50 | coordination-related | 1 |
| 51 | delphi-intervention | 1 |
| 52 | design/participants/main | 1 |
| 53 | doctor-report | 1 |
| 54 | doctor-reported | 1 |
| 55 | efficacy.our | 1 |
| 56 | eligible.primary | 1 |
| 57 | evidence.primary | 1 |
| 58 | fetoneonatal | 1 |
| 59 | fiber-level | 1 |
| 60 | functional/quality-of-life | 1 |
| 61 | gender-comparative | 1 |
| 62 | haemoglobin-related | 1 |
| 63 | hot-stress | 1 |
| 64 | infant-junior | 1 |
| 65 | l-ribulose | 1 |
| 66 | laudatory | 1 |
| 67 | less.we | 1 |
| 68 | longer-waited | 1 |
| 69 | longerterm | 1 |
| 70 | macedonia.the | 1 |
| 71 | maintenance/relapse | 1 |
| 72 | maternal/foetal | 1 |
| 73 | mesh-matching | 1 |
| 74 | midterms | 1 |
| 75 | mini-prophylaxis | 1 |
| 76 | minor/secondary | 1 |
| 77 | months.secondary | 1 |
| 78 | mp-reactive | 1 |
| 79 | neurodevelomental | 1 |
| 80 | non-atp-producing | 1 |
| 81 | non-psa-related | 1 |
| 82 | noncriminal | 1 |
| 83 | nondiagonal | 1 |
| 84 | nonrewarding | 1 |
| 85 | opioid-relapse | 1 |
| 86 | ostomy.the | 1 |
| 87 | parks-based | 1 |
| 88 | patient-effectiveness | 1 |
| 89 | patient-relevant/disease-specific | 1 |
| 90 | patients.secondary | 1 |
| 91 | perinatal/maternal | 1 |
| 92 | perioperative/short-term | 1 |
| 93 | plant-generated | 1 |
| 94 | pmi-related | 1 |
| 95 | post-1980 | 1 |
| 96 | postregimen | 1 |
| 97 | postyear-1 | 1 |
| 98 | preinatal | 1 |
| 99 | prevention-fracture | 1 |
| 100 | preventionsuccessful | 1 |
| 101 | professional-centered | 1 |
| 102 | programme-related | 1 |
| 103 | rates.various | 1 |
| 104 | referral/treatment | 1 |
| 105 | relief.secondary | 1 |
| 106 | response/ritual | 1 |
| 107 | responsive-to-change | 1 |
| 108 | sarcopenia-related | 1 |
| 109 | scale.secondary | 1 |
| 110 | secondary/explorative | 1 |
| 111 | secondary/intermediate | 1 |
| 112 | selective/indicated | 1 |
| 113 | seroma-related | 1 |
| 114 | setting/main | 1 |
| 115 | smoke-independent | 1 |
| 116 | sphingolipid-related | 1 |
| 117 | subgroup/treatment | 1 |
| 118 | subject/partner | 1 |
| 119 | subject/partner-reported | 1 |
| 120 | therepeutic | 1 |
| 121 | visible-light-mediated | 1 |
| 122 | xlf-dependent | 1 |
| 123 | ~bullet~fall | 1 |
| 124 | α-hydroxynitrosamine | 1 |
| 1 | 'eczema | 1 |
| 2 | 'rapidly | 3 |
| 3 | .feasibility | 1 |
| 4 | /secondary | 1 |
| 5 | 23-step | 1 |
| 6 | 6-7-year | 1 |
| 7 | adult-provided | 1 |
| 8 | after-baseline | 1 |
| 9 | agency-level | 1 |
| 10 | b-efficacy | 1 |
| 11 | background/ | 1 |
| 12 | behavioral/physiological | 1 |
| 13 | binary/dichotomous | 1 |
| 14 | c-radiographic | 1 |
| 15 | careconnections | 1 |
| 16 | carer-related | 3 |
| 17 | caseworker-level | 1 |
| 18 | co-primary | 281 |
| 19 | co-secondary | 2 |
| 20 | cognitive/psychosocial | 1 |
| 21 | composite-outcomes | 1 |
| 22 | consultations.commonly-occurring | 1 |
| 23 | coordination-related | 1 |
| 24 | coprimary | 226 |
| 25 | delphi-intervention | 1 |
| 26 | design/participants/main | 1 |
| 27 | developmental/cognitive | 2 |
| 28 | doctor-report | 1 |
| 29 | doctor-reported | 1 |
| 30 | efficacy.our | 1 |
| 31 | eligible.primary | 1 |
| 32 | evidence.primary | 1 |
| 33 | exposure/response | 10 |
| 34 | fetal/neonatal/infant | 2 |
| 35 | fetoneonatal | 1 |
| 36 | fiber-level | 1 |
| 37 | functional/quality-of-life | 1 |
| 38 | gender-comparative | 1 |
| 39 | haemoglobin-related | 1 |
| 40 | harmonizing | 76 |
| 41 | harms/harm-related | 3 |
| 42 | hiv/sti/pregnancy | 4 |
| 43 | hot-stress | 1 |
| 44 | icu-related | 2 |
| 45 | infant-junior | 1 |
| 46 | interventionsprimary | 2 |
| 47 | l-ribulose | 1 |
| 48 | late-appearing | 4 |
| 49 | laudatory | 1 |
| 50 | less.we | 1 |
| 51 | longer-waited | 1 |
| 52 | longerterm | 1 |
| 53 | macedonia.the | 1 |
| 54 | maintenance/relapse | 1 |
| 55 | maternal/foetal | 1 |
| 56 | mesh-matching | 1 |
| 57 | midterms | 1 |
| 58 | mini-prophylaxis | 1 |
| 59 | minor/secondary | 1 |
| 60 | months.secondary | 1 |
| 61 | mp-reactive | 1 |
| 62 | multiple-approach | 2 |
| 63 | neurodevelomental | 1 |
| 64 | non-atp-producing | 1 |
| 65 | non-psa-related | 1 |
| 66 | non-substantive | 2 |
| 67 | non-vocational | 4 |
| 68 | noncriminal | 1 |
| 69 | nondiagonal | 1 |
| 70 | nonrewarding | 1 |
| 71 | opioid-relapse | 1 |
| 72 | ostomy.the | 1 |
| 73 | parks-based | 1 |
| 74 | patient-effectiveness | 1 |
| 75 | patient-relevant/disease-specific | 1 |
| 76 | patients.secondary | 1 |
| 77 | perinatal/maternal | 1 |
| 78 | perioperative/short-term | 1 |
| 79 | plant-generated | 1 |
| 80 | pmi-related | 1 |
| 81 | poor/death | 2 |
| 82 | post-1980 | 1 |
| 83 | postregimen | 1 |
| 84 | postyear-1 | 1 |
| 85 | preinatal | 1 |
| 86 | prevention-fracture | 1 |
| 87 | preventionsuccessful | 1 |
| 88 | professional-centered | 1 |
| 89 | programme-related | 1 |
| 90 | prolapse-specific | 2 |
| 91 | rates.various | 1 |
| 92 | referral/treatment | 1 |
| 93 | relief.secondary | 1 |
| 94 | reperfusion-related | 4 |
| 95 | response/ritual | 1 |
| 96 | responsive-to-change | 1 |
| 97 | sarcopenia-related | 1 |
| 98 | scale.secondary | 1 |
| 99 | secondary | 31,196 |
| 100 | secondary/explorative | 1 |
| 101 | secondary/exploratory | 2 |
| 102 | secondary/intermediate | 1 |
| 103 | secundary | 2 |
| 104 | selective/indicated | 1 |
| 105 | seroma-related | 1 |
| 106 | setting/main | 1 |
| 107 | smoke-independent | 1 |
| 108 | smoker-level | 2 |
| 109 | sphingolipid-related | 1 |
| 110 | stimulant-use | 4 |
| 111 | subgroup/treatment | 1 |
| 112 | subject/partner | 1 |
| 113 | subject/partner-reported | 1 |
| 114 | surgeon-administered | 2 |
| 115 | therepeutic | 1 |
| 116 | time/cost | 4 |
| 117 | treatment.secondary | 2 |
| 118 | ttt/ttt | 4 |
| 119 | visible-light-mediated | 1 |
| 120 | within-drug | 2 |
| 121 | xlf-dependent | 1 |
| 122 | xylazine-induced | 2 |
| 123 | ~bullet~fall | 1 |
| 124 | α-hydroxynitrosamine | 1 |
| 1 | background/ | 1 |
| 2 | post-1980 | 1 |
| 3 | postyear-1 | 1 |
| 4 | 'eczema | 1 |
| 5 | patient-relevant/disease-specific | 1 |
| 6 | prolapse-specific | 2 |
| 7 | c-radiographic | 1 |
| 8 | therepeutic | 1 |
| 9 | xylazine-induced | 2 |
| 10 | adult-provided | 1 |
| 11 | professional-centered | 1 |
| 12 | surgeon-administered | 2 |
| 13 | parks-based | 1 |
| 14 | selective/indicated | 1 |
| 15 | visible-light-mediated | 1 |
| 16 | sarcopenia-related | 1 |
| 17 | seroma-related | 1 |
| 18 | non-psa-related | 1 |
| 19 | sphingolipid-related | 1 |
| 20 | programme-related | 1 |
| 21 | pmi-related | 1 |
| 22 | harms/harm-related | 3 |
| 23 | haemoglobin-related | 1 |
| 24 | reperfusion-related | 4 |
| 25 | coordination-related | 1 |
| 26 | carer-related | 3 |
| 27 | icu-related | 2 |
| 28 | plant-generated | 1 |
| 29 | longer-waited | 1 |
| 30 | subject/partner-reported | 1 |
| 31 | doctor-reported | 1 |
| 32 | functional/quality-of-life | 1 |
| 33 | responsive-to-change | 1 |
| 34 | macedonia.the | 1 |
| 35 | ostomy.the | 1 |
| 36 | after-baseline | 1 |
| 37 | α-hydroxynitrosamine | 1 |
| 38 | prevention-fracture | 1 |
| 39 | exposure/response | 10 |
| 40 | l-ribulose | 1 |
| 41 | opioid-relapse | 1 |
| 42 | maintenance/relapse | 1 |
| 43 | stimulant-use | 4 |
| 44 | secondary/intermediate | 1 |
| 45 | gender-comparative | 1 |
| 46 | secondary/explorative | 1 |
| 47 | mp-reactive | 1 |
| 48 | developmental/cognitive | 2 |
| 49 | non-substantive | 2 |
| 50 | less.we | 1 |
| 51 | non-atp-producing | 1 |
| 52 | nonrewarding | 1 |
| 53 | mesh-matching | 1 |
| 54 | late-appearing | 4 |
| 55 | consultations.commonly-occurring | 1 |
| 56 | harmonizing | 76 |
| 57 | within-drug | 2 |
| 58 | multiple-approach | 2 |
| 59 | poor/death | 2 |
| 60 | behavioral/physiological | 1 |
| 61 | cognitive/psychosocial | 1 |
| 62 | noncriminal | 1 |
| 63 | nondiagonal | 1 |
| 64 | non-vocational | 4 |
| 65 | perinatal/maternal | 1 |
| 66 | preinatal | 1 |
| 67 | fetoneonatal | 1 |
| 68 | maternal/foetal | 1 |
| 69 | neurodevelomental | 1 |
| 70 | response/ritual | 1 |
| 71 | fiber-level | 1 |
| 72 | smoker-level | 2 |
| 73 | caseworker-level | 1 |
| 74 | agency-level | 1 |
| 75 | ~bullet~fall | 1 |
| 76 | preventionsuccessful | 1 |
| 77 | perioperative/short-term | 1 |
| 78 | longerterm | 1 |
| 79 | postregimen | 1 |
| 80 | setting/main | 1 |
| 81 | design/participants/main | 1 |
| 82 | delphi-intervention | 1 |
| 83 | 23-step | 1 |
| 84 | 6-7-year | 1 |
| 85 | subject/partner | 1 |
| 86 | infant-junior | 1 |
| 87 | efficacy.our | 1 |
| 88 | composite-outcomes | 1 |
| 89 | mini-prophylaxis | 1 |
| 90 | midterms | 1 |
| 91 | careconnections | 1 |
| 92 | patient-effectiveness | 1 |
| 93 | hot-stress | 1 |
| 94 | rates.various | 1 |
| 95 | binary/dichotomous | 1 |
| 96 | fetal/neonatal/infant | 2 |
| 97 | xlf-dependent | 1 |
| 98 | smoke-independent | 1 |
| 99 | referral/treatment | 1 |
| 100 | subgroup/treatment | 1 |
| 101 | doctor-report | 1 |
| 102 | time/cost | 4 |
| 103 | ttt/ttt | 4 |
| 104 | b-efficacy | 1 |
| 105 | hiv/sti/pregnancy | 4 |
| 106 | 'rapidly | 3 |
| 107 | secondary | 31,196 |
| 108 | co-secondary | 2 |
| 109 | scale.secondary | 1 |
| 110 | relief.secondary | 1 |
| 111 | months.secondary | 1 |
| 112 | patients.secondary | 1 |
| 113 | treatment.secondary | 2 |
| 114 | /secondary | 1 |
| 115 | minor/secondary | 1 |
| 116 | secundary | 2 |
| 117 | co-primary | 281 |
| 118 | evidence.primary | 1 |
| 119 | eligible.primary | 1 |
| 120 | coprimary | 226 |
| 121 | interventionsprimary | 2 |
| 122 | laudatory | 1 |
| 123 | secondary/exploratory | 2 |
| 124 | .feasibility | 1 |